KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Current Assets (2016 - 2026)

Bio-Rad Laboratories has reported Current Assets over the past 18 years, most recently at $2.9 billion for Q1 2026.

  • Quarterly Current Assets fell 3.11% to $2.9 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.9 billion through Mar 2026, down 3.11% year-over-year, with the annual reading at $2.9 billion for FY2025, 4.1% down from the prior year.
  • Current Assets was $2.9 billion for Q1 2026 at Bio-Rad Laboratories, up from $2.9 billion in the prior quarter.
  • Over five years, Current Assets peaked at $3.3 billion in Q1 2022 and troughed at $2.8 billion in Q2 2025.
  • The 5-year median for Current Assets is $3.1 billion (2024), against an average of $3.1 billion.
  • Year-over-year, Current Assets soared 58.65% in 2022 and then fell 8.02% in 2025.
  • A 5-year view of Current Assets shows it stood at $3.2 billion in 2022, then dropped by 3.47% to $3.0 billion in 2023, then dropped by 0.59% to $3.0 billion in 2024, then fell by 4.1% to $2.9 billion in 2025, then increased by 1.24% to $2.9 billion in 2026.
  • Per Business Quant, the three most recent readings for BIO's Current Assets are $2.9 billion (Q1 2026), $2.9 billion (Q4 2025), and $2.8 billion (Q3 2025).